Valuation : Enovis Corporation

Market Cap 106.17Cr 92Cr 87Cr 78Cr 147.25Cr 10TCr 148.12Cr 1.03TCr 395.49Cr 5.16TCr 398.72Cr 389.92Cr 16TCr P/E 2026 *
91.1x
P/E 2027 * 23.5x
Enterprise Value 236.59Cr 204.03Cr 193.08Cr 174.91Cr 328.13Cr 23TCr 330.07Cr 2.29TCr 881.34Cr 11TCr 888.53Cr 868.91Cr 36TCr EV / Sales 2026 *
1.01x
EV / Sales 2027 * 0.93x
Free-Float
98.36%
Yield 2026 *
-
Yield 2027 * -
1 day+4.73%
1 week-0.62%
Current month-21.59%
1 month-20.46%
3 months-12.24%
6 months-19.30%
Current year-27.63%
1 week 18.08
Extreme 18.08
20.22
1 month 18.08
Extreme 18.08
27.46
Current year 18.08
Extreme 18.08
31.66
1 year 18.08
Extreme 18.08
34.28
3 years 18.08
Extreme 18.08
65.03
5 years 18.08
Extreme 18.08
164.01
10 years 18.08
Extreme 18.08
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap. Importance
04/09/26 Buy

Chief Administrative Officer

2,660 0.0047%
04/09/26 Buy

Chief Executive Officer

13,035 0.0228%
03/09/26 Buy

Chief Administrative Officer

5,140 0.0090%
Change 5-day change 1-year change 3-year change Capi.($)
+4.73%-0.62%-36.70%-64.32% 106.17Cr
+2.06%-10.53%-28.05%-4.83% 10TCr
-1.66%-4.13%-28.63%-5.48% 1.17TCr
-1.84%-7.26%+91.10%+124.86% 1TCr
-1.34%-3.93%-55.03%-71.49% 399.05Cr
-2.84%-6.02%-30.57%+30.74% 239.98Cr
+7.16%+17.48%-7.33%-67.49% 196.94Cr
+1.47%-6.79% - - 181.49Cr
-2.10%-3.88%-24.51%-29.82% 152.9Cr
Average +0.63%-3.95%-14.96%-10.98% 1.53TCr
Weighted average by Cap. +1.32%-10.13%-19.87%+1.70%

Financials

2026 *2027 *
Net sales 233.97Cr 201.77Cr 190.94Cr 172.97Cr 324.49Cr 22TCr 326.41Cr 2.27TCr 871.56Cr 11TCr 878.67Cr 859.27Cr 36TCr 245.41Cr 211.64Cr 200.28Cr 181.43Cr 340.36Cr 23TCr 342.37Cr 2.38TCr 914.19Cr 12TCr 921.65Cr 901.31Cr 38TCr
Net income 1.13Cr 97.66L 92.42L 83.73L 1.57Cr 108.2Cr 1.58Cr 11Cr 4.22Cr 55Cr 4.25Cr 4.16Cr 173.9Cr 3.9Cr 3.36Cr 3.18Cr 2.88Cr 5.41Cr 372.61Cr 5.44Cr 38Cr 15Cr 189.36Cr 15Cr 14Cr 598.86Cr
Net Debt 130.42Cr 112.47Cr 106.44Cr 96Cr 180.89Cr 12TCr 181.95Cr 1.26TCr 485.84Cr 6.33TCr 489.81Cr 479Cr 20TCr 121.25Cr 104.56Cr 99Cr 90Cr 168.16Cr 12TCr 169.15Cr 1.17TCr 451.66Cr 5.89TCr 455.35Cr 445.3Cr 19TCr
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
11/26/11 $19.28 +4.73% 25,54,374
10/26/10 $18.41 -3.26% 17,62,601
09/26/09 $19.03 -4.75% 18,79,438
08/26/08 $19.98 +7.65% 37,43,670
04/26/04 $18.56 -4.33% 18,86,851
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
18.41USD
Average target price
38.33USD
Spread / Average Target
+108.22%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!